Swiss Medtech Award 2024: The top 3 nominees have been chosen

Ivoclar, Oertli Instrumente AG, and Sentec nominated for this year’s award

Three successful Swiss companies, Ivoclar (Schaan), Oertli Instrumente AG (Berneck), and Sentec (Therwil) have been nominated for this year’s Swiss Medtech Award. The jury made their decision after hearing presentations by the nomination committee who had submitted a total of 17 Swiss companies for consideration. Jury President Prof. Mirko Meboldt, ETH Zurich, praised the achievements of the top three, stating «These three established companies are groundbreaking innovators in their respective fields who have not only set technological benchmarks, but more importantly, new standards for user-centred innovation in patient care».

The top achievements of the three nominated companies

  • Ivoclar – Integrated solutions for high-quality dental applications: The Ivoclar Group, headquartered in Schaan, Liechtenstein, is one of the world’s leading manufacturers of integrated solutions for high-quality dental applications. Throughout its 100-year history, the Ivoclar Group’s numerous innovations have significantly influenced the dental industry. One particularly ground-breaking technology involved the development of all-ceramic materials and the required supporting equipment. Among other things, this innovation has set new standards in esthetic dentistry and fundamentally changed the way dental laboratories, dentists, and patients interact with each other. More about Ivoclar
  • Oertli Instrumente AG – Top performance in opthamology: This family run company develops, produces, and distributes surgical operating platforms, instruments, and consumables that enable surgeons and surgical staff to perform operations more easily, safely, and efficiently – ultimately achieving better results for patients. The surgical platforms manufactured in Eastern Switzerland can be used to perform cataract, glaucoma, and complex retinal surgery. The company enjoys worldwide recognition, and its 407 employees contribute daily to ensure over 2 million people retain or regain their sight every year. More about Oertli Instrumente AG
  • Sentec – non-invasive respiratory monitoring for less invasive treatments: Sentec has been a market leader since 1999, providing clinicians with an efficient portfolio of technological solutions for the care of patients with respiratory diseases. Sentec has gained worldwide recognition for its digital, combined transcutaneous sensor systems that enable non-invasive and continuous monitoring of respiration and blood gas levels. Furthermore, Sentec develops, manufactures, and distributes systems and accessories for electrical impedance tomography (which enables non-invasive images of lung function), as well as percussive high-frequency airway clearance devices for patients. More about Sentec

About the Swiss Medtech Award

Swiss Medtech first launched the Swiss Medtech Award competition in 2018. The prize money of CHF 75,000 – sponsored by the Sonova Group, Straumann Group, and Ypsomed – recognises outstanding achievements in the Swiss medical technology industry. The jury chaired by Prof. Mirko Meboldt, ETH Zurich, evaluates candidates based on patient benefit, improvements in healthcare, and technological pioneering spirit. The winning team is announced and honoured annually at Swiss Medtech Day, the most important event for the Swiss medical technology industry. More about the Swiss Medtech Award

Swiss Medtech represents more than 750 members in its role as industry association for Swiss medical technology. With 67,500 employees and a contribution of 11.5% to the positive trade balance, medical technology is an economically significant sector in Switzerland. Swiss Medtech advocates for conditions that enable the medtech industry to perform at peak capacity and provide first-class medical care.